The marketing authorization holder has informed its supplied customers in a letter dated April 23, 2018, that a reduced ethanol content was detected during routine release testing. Therefore, the batch 7F307A on the market is recalled as a precautionary measure.
|Name of the medicinal product
|Taxotere 20mg/1ml Konzentrat zur Herstellung einer Infusionslösung
|Marketing authorisation number(s)
|Marketing authorisation holder
|Aventis Pharma Specialites S.A.
|Classification of the recall
|BASG reference number